STOCKS | Psychedelic Therapy Stocks Surge After Executive Order

Shares of companies involved in psychedelic-related therapies are experiencing a surge in premarket trading. Bloomberg posted on X that this follows U.S. President Donald Trump's signing of an executive order aimed at expediting research and access to these therapies. The move is expected to significantly impact the industry, as it could lead to faster development and availability of psychedelic treatments. Investors are reacting positively to the news, anticipating potential growth and innovation in the sector.